ORAGENICS, INC. Additional Paid in Capital, Common Stock
ORAGENICS, INC. (OGEN) had Additional Paid in Capital, Common Stock of $97.85 million as of 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2017-08-14
- 2017-06-30: Additional Paid in Capital, Common Stock $97.85M.
- 2017-03-31: Additional Paid in Capital, Common Stock $97.79M.
- 2016-12-31: Additional Paid in Capital, Common Stock $97.62M.
- 2016-09-30: Additional Paid in Capital, Common Stock $97.45M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2017-06-30 | $97.85M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $97.79M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $97.62M 10-Q · filed 2017-08-14 |
| 2016-09-30 | $97.45M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $97.22M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $92.55M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $92.35M 10-K · filed 2017-02-27 |
| 2015-09-30 | $86.90M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $86.63M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $86.36M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $86.24M 10-K · filed 2016-03-30 |
| 2014-09-30 | $86.25M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $86.21M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $85.96M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $85.96M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |